Skip to main content
NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. ABOUT ABOUT NEUROAID ▸ safety profile ▸ composition & dosage ▸ CLINIcal studies ▸ HOME ABOUT ▾ library contact order Medical Professionals
Find out if neuroaid is right for you 🧠🦴 Study Highlights Elevated Cardiovascular Risks in Spinal Cord Injury Patients

📰🧠 🦴 SPINE CORD INJURY (SCI) STUDY HIGHLIGHTS – Spinal Cord Injury and Risk of Overall and Type-Specific Cardiovascular Disease: A Meta-Analysis by Luo S, Wu T, Cheng X.

The paper “Spinal Cord Injury and Risk of Overall and Type-Specific Cardiovascular Disease: A Meta-Analysis” holds critical importance. It highlights the well-documented increased incidence of cardiovascular disease and mortality in individuals with spinal cord injuries compared to the general population.

This meta-analysis provides a comprehensive summary of the heightened cardiovascular disease (CVD) risks, emphasizing the importance for clinicians to prioritize screening, prevention, and optimized treatment for cardiovascular disease in SCI patients.

Access the full article at: Luo S, Wu T, Cheng X. Spinal cord injury and risk of overall and type specific cardiovascular diseases: A meta-analysis. PLoS One. 2024;19(10):e0311572. Published 2024 Oct 28. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0311572. This article is licensed under a CC-BY license.

Close Menu